Impact of radiotherapy pattern on the prognosis of stage IV lung adenocarcinomas harboring EGFR mutations

被引：0
|
作者：
Zhang, Y. [1 ]
Wang, W. [1 ]
Li, J. [1 ]
Li, Z. [1 ]
Li, Y. [2 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Dept Radiat Oncol, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1839
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1234P
引用
收藏
页码：S976 / S976
页数：1
相关论文
共 50 条
  • [31] Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations
    Li, Teng
    Wang, Shouzheng
    Ying, Jianming
    Wang, Yan
    Hu, Xingsheng
    Hao, Xuezhi
    Xu, Ziyi
    Xing, Puyuan
    Li, Junling
    THORACIC CANCER, 2021, 12 (21) : 2924 - 2932
  • [32] Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type
    Ninomiya, Hironori
    Hiramatsu, Miyako
    Inamuraa, Kentaro
    Nomura, Kimie
    Okui, Michiyo
    Miyoshi, Tatsu
    Okumura, Sakae
    Satoh, Yukitoshi
    Nakagawa, Ken
    Nishio, Makoto
    Horai, Takeshi
    Miyata, Satoshi
    Tsuchiya, Eiju
    Fukayama, Masashi
    Ishikawa, Yuichi
    LUNG CANCER, 2009, 63 (02) : 235 - 240
  • [33] A case of multiple synchronous lung adenocarcinomas with differing EGFR mutations
    Hasegawa, Hideomi
    Kimura, Hideki
    Shingyoji, Masato
    Itami, Makiko
    Araki, Akinobu
    Yokoi, Sana
    Kageyama, Hajime
    Iizasa, Toshihiko
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2013, 2 (04): : 224 - 228
  • [34] Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas
    Eng, Juliana
    Woo, Kaitlin M.
    Sima, Camelia S.
    Plodkowski, Andrew
    Hellmann, Matthew D.
    Chaft, Jamie E.
    Kris, Mark G.
    Arcila, Maria E.
    Ladanyi, Marc
    Drilon, Alexander
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1713 - 1719
  • [35] EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations
    Marks, Jenifer L.
    Golas, Ben
    Kirchoff, Tomas
    Miller, Vincent A.
    Riely, Gregory J.
    Offit, Kenneth
    Pao, William
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 805 - 805
  • [36] A case of multiple synchronous lung adenocarcinomas with differing EGFR mutations
    Hideomi Hasegawa
    Hideki Kimura
    Masato Shingyoji
    Makiko Itami
    Akinobu Araki
    Sana Yokoi
    Hajime Kageyama
    Toshihiko Iizasa
    International Cancer Conference Journal, 2013, 2 (4) : 224 - 228
  • [37] Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans
    Reinersman, J. Matthew
    Johnson, Melissa L.
    Riely, Gregory J.
    Chitale, Dhananjay A.
    Nicastri, Anthony D.
    Soff, Gerald A.
    Schwartz, Ann G.
    Sima, Camelia S.
    Ayalew, Getinet
    Lau, Christopher
    Zakowski, Maureen F.
    Rusch, Valerie W.
    Ladanyi, Marc
    Kris, Mark G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 28 - 31
  • [38] Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas
    Sonobe, Makoto
    Kobayashi, Masashi
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Nakayama, Ei
    Takahashi, Tsuyoshi
    Menju, Toshi
    Takenaka, Kazumasa
    Miyahara, Ryo
    Huang, Cheng-Long
    Okubo, Kenichi
    Bando, Toru
    Date, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S347 - S354
  • [39] Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas
    Makoto Sonobe
    Masashi Kobayashi
    Masashi Ishikawa
    Ryutaro Kikuchi
    Ei Nakayama
    Tsuyoshi Takahashi
    Toshi Menju
    Kazumasa Takenaka
    Ryo Miyahara
    Cheng-Long Huang
    Kenichi Okubo
    Toru Bando
    Hiroshi Date
    Annals of Surgical Oncology, 2012, 19 : 347 - 354
  • [40] Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping (vol 5, pg 842, 2015)
    Paik, P. K.
    Drilon, A.
    Fan, P-D
    Yu, H.
    Rekhtman, N.
    Ginsberg, M. S.
    CANCER DISCOVERY, 2016, 6 (03) : 330 - 330
12345